While KMT2C is identified as a tumor suppressor in acute myeloid leukemia (AML), the role of KMT2D remains unclear in this disease, though its loss promotes B cell lymphoma and various solid cancers. This evidence concerns the gene KMT2D and B-cell non-Hodgkin lymphoma.